Barely Significant
← all excerpts

The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy.

Exp Mol Med · 2023 · PMC10238468 · PMID 37121970

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

markedly significantp < 0.001actually significant
Figure 8b shows a markedly significant difference in RMS between the CR and PD groups ( p < 0.001).

also in 412 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.